Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Drug Discovery Today
|
November 17, 2012
Low molecular weight heparins copies: are they considered to be generics or biosimilars?
Paola Minghetti, Francesco Cilurzo, Silvia Franzé, et al.
International Journal of Pharmaceutical Compounding
|
January 23, 2019
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Francesca Selmin, Antonella Casiraghi, Umberto M Musazzi, et al.
Advanced Healthcare Materials
|
September 17, 2023
Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges
Umberto M Musazzi, Silvia Franzè, Fabrizio Condorelli, et al.
Data in Brief
|
August 3, 2019
Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content
Giulia Magri, Silvia Franzé, Umberto M Musazzi, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
January 1, 1993
[The epidemiological aspects of head trauma due to road accidents. The cases of a hospital emergency service]
C Macchi, G M Manzella, R Mongiat, et al.
International Journal of Pharmaceutics
|
November 23, 2025
Relevant factors to guarantee quality of oligonucleotide-based products
Sara Azari, Sara Manellari, Giulia Anderluzzi, et al.
Journal of Integrative Medicine
|
June 16, 2022
Liver injury and dietary supplements: Does hydroxycitric acid trigger hepatotoxicity?
Andrea Zovi, Roberto Langella, Andrea Nisic, et al.
Data in Brief
|
November 21, 2018
Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance
Umberto M Musazzi, Antonella Casiraghi, Silvia Franzé, et al.
Drug Discovery Today
|
October 15, 2017
Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements
Francesco Cilurzo, Umberto M Musazzi, Silvia Franzé, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 24, 2019
Glatiramer acetate: A complex drug beyond biologics
Paolo Rocco, Ivano Eberini, Umberto M Musazzi, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Drug Discovery Today
|
November 17, 2012
Low molecular weight heparins copies: are they considered to be generics or biosimilars?
Paola Minghetti, Francesco Cilurzo, Silvia Franzé, et al.
International Journal of Pharmaceutical Compounding
|
January 23, 2019
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Francesca Selmin, Antonella Casiraghi, Umberto M Musazzi, et al.
Advanced Healthcare Materials
|
September 17, 2023
Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges
Umberto M Musazzi, Silvia Franzè, Fabrizio Condorelli, et al.
Data in Brief
|
August 3, 2019
Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content
Giulia Magri, Silvia Franzé, Umberto M Musazzi, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
January 1, 1993
[The epidemiological aspects of head trauma due to road accidents. The cases of a hospital emergency service]
C Macchi, G M Manzella, R Mongiat, et al.
International Journal of Pharmaceutics
|
November 23, 2025
Relevant factors to guarantee quality of oligonucleotide-based products
Sara Azari, Sara Manellari, Giulia Anderluzzi, et al.
Journal of Integrative Medicine
|
June 16, 2022
Liver injury and dietary supplements: Does hydroxycitric acid trigger hepatotoxicity?
Andrea Zovi, Roberto Langella, Andrea Nisic, et al.
Data in Brief
|
November 21, 2018
Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance
Umberto M Musazzi, Antonella Casiraghi, Silvia Franzé, et al.
Drug Discovery Today
|
October 15, 2017
Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements
Francesco Cilurzo, Umberto M Musazzi, Silvia Franzé, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 24, 2019
Glatiramer acetate: A complex drug beyond biologics
Paolo Rocco, Ivano Eberini, Umberto M Musazzi, et al.
Page
of 8